168 related articles for article (PubMed ID: 25204580)
1. Mooreamide A: a cannabinomimetic lipid from the marine cyanobacterium Moorea bouillonii.
Mevers E; Matainaho T; Allara' M; Di Marzo V; Gerwick WH
Lipids; 2014 Nov; 49(11):1127-32. PubMed ID: 25204580
[TBL] [Abstract][Full Text] [Related]
2. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.
Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V
J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413
[TBL] [Abstract][Full Text] [Related]
3. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
[TBL] [Abstract][Full Text] [Related]
5. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
[TBL] [Abstract][Full Text] [Related]
6. Cannabinomimetic lipid from a marine cyanobacterium.
Gutiérrez M; Pereira AR; Debonsi HM; Ligresti A; Di Marzo V; Gerwick WH
J Nat Prod; 2011 Oct; 74(10):2313-7. PubMed ID: 21999614
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system.
Kilaru A; Chapman KD
Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
9. Treatment of anorexia nervosa with palmitoylethanoamide.
Scolnick B
Med Hypotheses; 2018 Jul; 116():54-60. PubMed ID: 29857912
[No Abstract] [Full Text] [Related]
10. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
[TBL] [Abstract][Full Text] [Related]
11. Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
Han B; McPhail KL; Ligresti A; Di Marzo V; Gerwick WH
J Nat Prod; 2003 Oct; 66(10):1364-8. PubMed ID: 14575438
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of pyridone alkaloids on the endocannabinoid system.
Chicca A; Berg R; Jessen HJ; Marck N; Schmid F; Burch P; Gertsch J; Gademann K
Bioorg Med Chem; 2017 Nov; 25(22):6102-6114. PubMed ID: 28284861
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.
Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA
Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637
[TBL] [Abstract][Full Text] [Related]
15. Discovery and isolation of anandamide and other endocannabinoids.
Hanus LO
Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
[No Abstract] [Full Text] [Related]
16. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
Chicca A; Marazzi J; Gertsch J
Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
[TBL] [Abstract][Full Text] [Related]
17. Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo V; De Petrocellis L
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
19. Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease.
Kind L; Kursula P
Amino Acids; 2019 Feb; 51(2):151-174. PubMed ID: 30564946
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
